Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Adicet Bio Inc., 3 years.
Adicet Bio Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2023 | Adicet Bio Inc. | Grant or award | +5,900 | — | — |
| May 8, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −2,850 | $350.00 | $997,500 |
| May 5, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −422 | $350.03 | $147,713 |
| May 3, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −2,053 | $350.44 | $719,453 |
| May 3, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −728 | $351.60 | $255,965 |
| May 2, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −1,411 | $350.32 | $494,302 |
| May 2, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −42 | $351.65 | $14,769 |
| May 2, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −169 | $353.24 | $59,698 |
| Apr 12, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −874 | $325.70 | $284,662 |
| Apr 12, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −4,068 | $326.45 | $1,327,999 |
| Apr 12, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −2,625 | $327.43 | $859,504 |
| Apr 4, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −211 | $314.22 | $66,300 |
| Apr 4, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −94 | $315.66 | $29,672 |
| Apr 4, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −90 | $316.76 | $28,508 |
| Apr 4, 2023 | Vertex Pharmaceuticals Incorporated | Open-market sale | −96 | $317.65 | $30,494 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.